Articles
New Prostate Cancer Guidelines and ASPI Pathway
New Prostate Cancer Guidelines and ASPI Pathway: new guidelines for early low risk prostate cancer
Prostate Cancer and GU Pathology 2nd Opinions
Prostate Cancer and GU Pathology 2nd Opinions: Recommended providers for GU/prostate cancer pathology 2nd Opinions
PCPEP – The Prostate Cancer Patient Empowerment Program: Improve Your Quality of Life
PCPEP – The Prostate Cancer Patient Empowerment Program: Improve Your Quality of Life
2nd Opinions for MRIs
2nd Opinions for MRIs
AnCan GU ASCO26 survivorship poster: participants strongly endorse our Groups
AnCan GU ASCO26 survivorship poster: participants strongly endorse our Groups – 99% recommend AnCan Groups.
Telehealth gets extended through 2027!
Telehealth gets extended through 2027! Patients welcome teh return of more liberal telehealth rules with Feb 3, 2026 legislation. But there are still glitches!
Article Review – A Clear Guide to PCa Biomarkers
Article Review – A Clear Guide to PCa Biomarkers
Genomic Risk Classifiers: Similar, but Not the Same
Genomic Risk Classifiers: Similar, but Not the Same
ProstatID MRI 2nd Opinions
ProstatID MRI 2nd Opinions: getting a 3-D review of your prostate cancer MRI scans at low cost
Sharing AnCan with cancer researchers
Sharing AnCan with cancer researchers: ‘Prof’ Ben Nathanson is invited to introduce AnCan to the AACR at their April Conference.
Remembering Ken Mason
We are deeply saddened by the passing of Ken Mason, who was one of those cherished individuals.
AnCan welcomes Air Relief!
AnCan welcomes Air Relief – AnCan announces ‘new’ Executive addition